Ranking | Company (Ticker) | Year-to-Date Performance
1 HeartWare International, Inc. (NASDAQ:HTWR) 8721.6%
2 Vasogen Inc. (USA) (NASDAQ:IPCI) 2344.3%
3 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 1956.0%
4 Human Genome Sciences (NASDAQ:HGSI) 1191.5%
5 Opexa Therapeutics Inc. (NASDAQ:OPXA) 979.0%
Recent Comments